Zydus Wellness: The financial results for the period ended September 30, 2026
Zydus Wellness (ZYDUSWELL) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹15,377 crore.
What happened
Zydus Wellness (ZYDUSWELL) filed a disclosure with the exchanges on 3 November 2026 at 12:31 PM titled "The financial results for the period ended September 30, 2026".
Company snapshot
Zydus Wellness is a small-cap company in the Fast Moving Consumer Goods sector, with a market value of about ₹15,377 crore.
The stock last traded at ₹483.3, against a 52-week range of ₹367.6–₹611.9 (21.0% below the high).
Before this filing the shares had moved −9.8% over the month and −17.3% over three months. Average daily turnover over the last 20 sessions was about ₹4.69 crore.
Promoters held 69.64% at the end of Q1 FY27, up 0.01% points from the previous quarter. Foreign institutions owned 3.32% and domestic institutions 19.14%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 861 | 127.9 | 20.1 |
| Q2 FY26 | 651 | -52.8 | -1.66 |
| Q3 FY26 | 965 | -39.9 | -1.25 |
| Q4 FY26 | 1,485 | 162 | 5.09 |
| Q1 FY27 | 1,437 | 118.9 | 3.74 |
What history shows
This is not the company's first results disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.
Across 218 similar disclosures by other Fast Moving Consumer Goods companies, shares moved −0.9% on average the next day and −0.3% over five days; 38% of them rose the next day.
Market-wide, 10,321 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 3 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- FSSAI notices to Nestle India, Zydus Wellness over ‘misleading claims’ in products
- Nestle, Zydus Wellness Get Notices Over Claims About Infant Nutrition Products, Complan
- FSSAI issues notices to Zydus Wellness, Nestle India
- FSSAI issues notices to Nestle, Zydus Wellness over ‘misleading claims’ in Complan, Lactogen, Nan
- Nestle, Zydus Wellness shares plunge to six-month low amid FSSAI action
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.